Zymeworks (ZYME) Deferred Taxes (2021 - 2026)
Zymeworks recorded quarterly Deferred Taxes of $2.2 million in Q1 2026, up 256.03% quarter-over-quarter from -$1.4 million in Q4 2025, and up 436.59% year-over-year from $410000.0 in Q1 2025.
Zymeworks' Deferred Taxes history runs 6 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- In Q1 2026, Deferred Taxes rose 436.59% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $845000.0 (up 364.89% YoY), while the FY2025 annual figure was -$945000.0, down 36.76% from the prior year.
- Deferred Taxes came in at $2.2 million for Q1 2026 at Zymeworks, up from -$1.4 million in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $2.2 million in Q1 2026 to a low of -$1.9 million in Q4 2022.
- A 5-year average of -$36411.8 and a median of $38000.0 in 2024 frame the typical range for Deferred Taxes.
- Across the five-year window, Deferred Taxes slumped 249.76% in 2022 and jumped 978.95% in 2025, its largest moves.
- Zymeworks' Deferred Taxes stood at -$1.9 million in 2022, then jumped by 151.41% to $967000.0 in 2023, then slumped by 216.55% to -$1.1 million in 2024, then fell by 25.11% to -$1.4 million in 2025, then soared by 256.03% to $2.2 million in 2026.
- According to Business Quant data, Deferred Taxes over the past three periods registered $2.2 million, -$1.4 million, and $170000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -65.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 96.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 9.31 Mn |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.20 Mn |
| Dec 31, 2025 | -1.41 Mn |
| Sep 30, 2025 | 170,000.00 |
| Jun 30, 2025 | -115,000.00 |
| Mar 31, 2025 | 410,000.00 |
| Dec 31, 2024 | -1.13 Mn |
| Sep 30, 2024 | 204,000.00 |
| Jun 30, 2024 | 194,000.00 |
| Mar 31, 2024 | 38,000.00 |
| Dec 31, 2023 | 967,000.00 |
| Sep 30, 2023 | -95,000.00 |
| Jun 30, 2023 | -106,000.00 |
| Mar 31, 2023 | -9,000.00 |
| Dec 31, 2022 | -1.88 Mn |
| Sep 30, 2022 | 411,000.00 |
| Jun 30, 2022 | 265,000.00 |
| Mar 31, 2022 | -735,000.00 |
| Dec 31, 2021 | 1.26 Mn |